Bright Minds Biosciences

(NASDAQ) DRUG

Current Price$87.89

Market Cap$861.96M

Since IPO (2021)+226%

5 YearN/A

1 Year+222%

1 Month-1%

Bright Minds Biosciences Financials at a Glance

Market Cap

$861.96M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$27.53M

EPS (TTM)

-$2.44

P/E Ratio

-36.06

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$87.89

Volume

219,613

Open

$88.73

Price

$87.89

Volume

219,613

Open

$88.73

Previous Close

$88.07

Daily Range

$87.40 - $90.67

52-Week Range

$23.18 - $123.75

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$87.89

Volume

219,613

Open

$88.73

Previous Close

$88.07

Daily Range

$87.40 - $90.67

52-Week Range

$23.18 - $123.75

DRUG News

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline

Jonathan PoncianoMay 21, 2026

Person in a lab gazing into a microscope

Why Bright Minds Biosciences Stock Topped the Market on Monday

Eric VolkmanNov 17, 2025

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

David Jagielski, CPANov 13, 2024

DRUG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bright Minds Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ian B. McDonald

Website

www.brightmindsbio.com

Headquarters

New York City, BC V6E 4N7, CA

DRUG Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-15%

Return on Capital

-10%

Return on Assets

-9%

Earnings Yield

-2.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$861.96M

Shares Outstanding

9.79M

Volume

219.61K

Avg. Volume

187.06K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$13.94M

EBITDA

-CA$13.86M

Operating Cash Flow

-CA$8.69M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$8.69M

Cash & ST Invst.

CA$82.91M

Total Debt

CA$125.78K

Bright Minds Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$20.13K

N/A

Gross Margin

0.00%

N/A

Market Cap

$861.96M

N/A

Market Cap/Employee

$33.15M

N/A

Employees

N/A

Net Income

-CA$10.63M

-260.4%

EBITDA

-CA$15.55M

-367.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

CA$309.39M

+457.3%

Accounts Receivable

CA$1.14M

+387.7%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$82.13K

+5.6%

Return on Assets

-8.83%

N/A

Return on Invested Capital

-10.21%

N/A

Free Cash Flow

-CA$9.50M

-291.6%

Operating Cash Flow

-CA$9.50M

-291.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$27.97+1.60%

DSGNDesign Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.$10.48-2.42%

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.42+0.93%

IMABI-Mab

IMABI-Mab$2.88-0.69%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$7.47-0.40%

DMACDiaMedica Therapeutics Inc.

DMACDiaMedica Therapeutics Inc.$5.99-2.76%

ALTAltimmune, Inc.

ALTAltimmune, Inc.$3.05-0.65%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

TAT&T

TAT&T$24.80-0.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.64-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

Questions About DRUG

What is the current price of Bright Minds Biosciences?

Bright Minds Biosciences is trading at $88.07 per share.

What is the 52-week range for Bright Minds Biosciences?

Over the past 52 weeks, Bright Minds Biosciences has traded between $23.18 and $123.75.

How much debt does Bright Minds Biosciences have?

As of the most recent reporting period, Bright Minds Biosciences reported total debt of CA$58.85K.

How much cash does Bright Minds Biosciences have on hand?

Bright Minds Biosciences reported CA$221.79M in cash and cash equivalents in its most recent financial results.

What is Bright Minds Biosciences’s dividend yield?

Bright Minds Biosciences does not currently have a dividend yield.

Bright Minds Biosciences

Bright Minds Biosciences Financials at a Glance

DRUG News

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline

Why Bright Minds Biosciences Stock Topped the Market on Monday

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

DRUG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bright Minds Biosciences

DRUG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bright Minds Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DRUG

What is the current price of Bright Minds Biosciences?

What is the 52-week range for Bright Minds Biosciences?

How much debt does Bright Minds Biosciences have?

How much cash does Bright Minds Biosciences have on hand?

What is Bright Minds Biosciences’s dividend yield?

Premium Investing Services